HashiCorp Inc. (HCP)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Here's Why HashiCorp, Inc. (HCP) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why HashiCorp, Inc. (HCP) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HashiCorp, Inc. (HCP) Hit a 52 Week High, Can the Run Continue?
HashiCorp (HCP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HashiCorp (HCP) Upgraded to Buy: Here's What You Should Know
HashiCorp (HCP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Compared to Estimates, HashiCorp (HCP) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for HashiCorp (HCP) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Best Momentum Stocks to Buy for October 18th
ZM, HCP and MSGE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 18, 2024.
Healthpeak Properties Stock Up 16.5% in 6 Months: Will It Rise Further?
DOC to gain from robust demand for lab assets and an expected rise in senior citizens' healthcare spending, accretive investments and a solid balance sheet.
HashiCorp: Take The Easy Win
HashiCorp, Inc. is awaiting the closing of a deal with IBM. The stock still trades at a 3.4% discount to the acquisition price on fears the completion of the deal will be pushed into 2025. Whether it closes in 2 months or 4 months, this easy return is virtually risk-free and worth a long play.
HashiCorp (HCP) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for HashiCorp (HCP) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Here's Why HashiCorp, Inc. (HCP) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why HashiCorp, Inc. (HCP) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCP, BATL on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / June 14, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: HashiCorp Inc. (NASDAQ:HCP)'s sale to IBM for $35.00 per share in cash. If you are a HashiCorp shareholder, click here to learn more about your rights and options.
